IgGenix Inc.
South San Francisco, US · Founded 2019 · 8 employees on LinkedIn · 8 known investors
IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases. The company uses its proprietary SEQ SIFTER™ platform to develop first-in-class therapeutic antibodies targeting allergic cascades.
Founders & leadership
IgGenix Inc. was founded in 2019 by Kari Nadeau.
KN
Kari NadeauScientific Co-Founder
Investors · 8
Competitors · 4
by search overlapBioworld10 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
argenx10 shared keywordsThe company develops therapies for people with severe autoimmune diseases.
Phigenix9 shared keywordsPhigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
Origene7 shared keywordsOriGene develops and supplies genomic and proteomic research tools, including proteins and antibodies built on its proprietary cDNA clone collections, for life science researchers. The company offers a broad catalog of research products used in scientific discovery and diagnostics development.
Companies competing with IgGenix Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does IgGenix Inc. do?
- IgGenix is a clinical-stage biotechnology company focused on antibody discovery and development for allergies and immunological diseases. The company uses its proprietary SEQ SIFTER™ platform to develop first-in-class therapeutic antibodies targeting allergic cascades.
- Who founded IgGenix Inc.?
- IgGenix Inc. was founded by Kari Nadeau in 2019.
- Who are IgGenix Inc.'s investors?
- IgGenix Inc.'s investors include Khosla Ventures, Allerfund Ventures, Llc, FemHealth Ventures, Global Brain, Medical Incubator Japan K.K., ShangBay Capital LLC, Alexandria, SBI Investment.
- Where is IgGenix Inc. headquartered?
- IgGenix Inc. is headquartered in South San Francisco, US.